Molecular Modeling, Breast Cancer, and Hepatitis A, B, C Molecular Docking Investigation of (2E)-1-phenyl-butane-1,2,3-trione 2-[(2-oxo-2H-chromene-6-yl)hydrazone]
Abdou, A., Mostafa, H., Abdel-Mawgoud, A. (2022). Molecular Modeling, Breast Cancer, and Hepatitis A, B, C Molecular Docking Investigation of (2E)-1-phenyl-butane-1,2,3-trione 2-[(2-oxo-2H-chromene-6-yl)hydrazone]. EKB Journal Management System, 7(3), 167-173. doi: 10.21608/sjsci.2022.151396.1016
Aly Abdou; Hassan M. Mostafa; Abdel-Mawgoud M. Abdel-Mawgoud. "Molecular Modeling, Breast Cancer, and Hepatitis A, B, C Molecular Docking Investigation of (2E)-1-phenyl-butane-1,2,3-trione 2-[(2-oxo-2H-chromene-6-yl)hydrazone]". EKB Journal Management System, 7, 3, 2022, 167-173. doi: 10.21608/sjsci.2022.151396.1016
Abdou, A., Mostafa, H., Abdel-Mawgoud, A. (2022). 'Molecular Modeling, Breast Cancer, and Hepatitis A, B, C Molecular Docking Investigation of (2E)-1-phenyl-butane-1,2,3-trione 2-[(2-oxo-2H-chromene-6-yl)hydrazone]', EKB Journal Management System, 7(3), pp. 167-173. doi: 10.21608/sjsci.2022.151396.1016
Abdou, A., Mostafa, H., Abdel-Mawgoud, A. Molecular Modeling, Breast Cancer, and Hepatitis A, B, C Molecular Docking Investigation of (2E)-1-phenyl-butane-1,2,3-trione 2-[(2-oxo-2H-chromene-6-yl)hydrazone]. EKB Journal Management System, 2022; 7(3): 167-173. doi: 10.21608/sjsci.2022.151396.1016

Molecular Modeling, Breast Cancer, and Hepatitis A, B, C Molecular Docking Investigation of (2E)-1-phenyl-butane-1,2,3-trione 2-[(2-oxo-2H-chromene-6-yl)hydrazone]

Sohag Journal of Sciences
Volume 7, Issue 3, September 2022, Page 167-173  XML PDF (1.61 MB)
Document Type: Regular Articles
DOI: 10.21608/sjsci.2022.151396.1016
View on SCiNiTO View on SCiNiTO
Authors
Aly Abdou email orcid 1; Hassan M. Mostafa2; Abdel-Mawgoud M. Abdel-Mawgoud3
1Chemistry Department, Faculty of Science, Sohag University 82524, Egypt
2Sohag University, Faculty of Science
3Chemistry Department, Faculty of Science, Sohag University, Sohag 82524, Egypt
Abstract
Abstract: Density Functional Theory (DFT) was used to optimize the geometry of (2E)-1-phenyl-butane-1,2,3-trione 2-[(2-oxo-2H-chromene-6-yl)hydrazone]. The DFT computations were based on the B3LYP/6-311G (d, p) level. For the optimized structure, the border molecular orbital, the highest occupied molecular orbital (HOMO), the lowest unoccupied molecular orbital (LUMO), the molecular electrostatic potential (MEP), and a Mulliken population analysis have been done. At the same theoretical level, the vibrational frequencies (FT-IR) of the titled compound were determined and scaled down using a factor of 0.961. Also, at the same level of theory, the electronic spectrum of the mentioned molecule was theoretically estimated using Time-Dependent Density Functional Theory (TD-DFT) in gas phase. The mentioned molecule was subjected to molecular docking investigations to determine its inhibitory activity against the breast cancer receptor (PDB ID: 3I89), the HCV receptor (PDB ID: 5TRH), the HBV receptor (PDB ID: 5T2P), and the HAV receptor (PDB ID: 5WTG). According to the findings, the aforementioned compound has a higher maximum binding affinity for HBV than the others do. Consequently, it might be a good candidate for an antiviral therapy.
Keywords
DFT HOMO; LUMO; MEP; Molecular docking; breast cancer; HCV; HBV; HAV
Statistics
Article View: 2,035
PDF Download: 812